QuickVue+ 20122

by Quidel Corp.

QuickVue+ 20122 is a Class I device made by Quidel Corp., listed in FDA GUDID since 10 Nov 2018 (UDI-DI 30014613201229), registry data as of 23 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

Region	Authorization	Number	Date	Status
United States	GUDID listing	Number30014613201229 UDI-DI	Date10 Nov 2018Listed	StatusListed GUDID: in commercial distribution

Official records

AccessGUDID record UDI-DI 30014613201229

Coverage

1 jurisdiction

Active
Expiring
Withdrawn
Listed
Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name: QuickVue+
Generic name: Beta-haemolytic Group A Streptococcus antigen IVD, kit, rapid ICT, clinical
Model / Ref / Catalog: 20122

Primary DI / UDI-DI: 30014613201229
FDA product code: GTZ
GMDN term: Beta-haemolytic Group A Streptococcus antigen IVD, kit, rapid ICT, clinical

Device class: Class I
Regulation number: 866.3740
GUDID distribution status: In Commercial Distribution

Similar devices in this category

Other devices filed under Beta-haemolytic Group A Streptococcus antigen IVD, kit, rapid ICT, clinical.

Other devices from Quidel Corp.

QuickVue 20125 Open recall

Class I
Sofia 20253

Class I
MicroVue C1-Inhibitor

Class II
Sofia 20298

Class II

See all devices from Quidel Corp. →

Properties

Single use
Prescription use
Convenience kit
Lot / batch number
Expiration date

Other properties (10, all answered No)